key: cord-0809190-8vlxwnja
authors: Kam, K.-q.; Thoon, K. C.; Maiwald, M.; Chong, C. Y.; Soong, H. Y.; Loo, L. H.; Tan, W. H. N.; Li, J.; Nadua, K. D.; Yung, C. F.
title: SARS-CoV-2 Viral RNA Load Dynamics in the Nasopharynx of Infected Children
date: 2020-09-02
journal: nan
DOI: 10.1101/2020.08.31.20185488
sha: e10b2924b7d83ba198aa4a75ab2143a4d33536e4
doc_id: 809190
cord_uid: 8vlxwnja

It is important to understand the temporal trend of pediatric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load to estimate the transmission potential of children in schools and communities. We determined differences in SARS-CoV-2 viral load dynamics between nasopharyngeal samples of infected asymptomatic and symptomatic children. The daily cycle threshold values of SARS-CoV-2 in the nasopharynx of a cohort of infected children were collected for analysis. Among 17 infected children, 10 (58.8%) were symptomatic. Symptomatic children, when compared to asymptomatic children, had higher viral load (mean cycle threshold on day 7 of illness 28.6 versus 36.7, p = 0.02). Peak SARS-CoV-2 viral loads occured around days 2-3 of illness/days of diagnosis in infected children. After adjusting for the estimated date of infection, the higher SARS-CoV-2 viral loads in symptomatic children remained. We postulate that symptomatic SARS-CoV-2-infected children may have higher transmissibility than asymptomatic children. As peak viral load in infected children occurred in the early stage of illness, viral shedding and transmission in the pre-symptomatic phase probable. Our study highlights the importance of screening for SARS-CoV-2 in children with epidemiological risk factors, even when they are asymptomatic in order to improve containment of the virus in the community, including educational settings.

CoV-2 viral loads occured around days 2-3 of illness/days of diagnosis in infected children. 28

After adjusting for the estimated date of infection, the higher SARS-CoV-2 viral loads in 29 symptomatic children remained. We postulate that symptomatic SARS-CoV-2-infected 30 children may have higher transmissibility than asymptomatic children. As peak viral load in 31 infected children occurred in the early stage of illness, viral shedding and transmission in the 32 pre-symptomatic phase probable. Our study highlights the importance of screening for 33 SARS-CoV-2 in children with epidemiological risk factors, even when they are asymptomatic 34 in order to improve containment of the virus in the community, including educational 35 settings. 36 37

• Symptomatic children had higher SARS-CoV-2 viral loads in the nasopharynx than 39 asymptomatic children, which may indicate that symptomatic children have higher 40 transmissibility. 41 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted September 2, 2020. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted September 2, 2020. . https://doi.org/10.1101/2020.08.31.20185488 doi: medRxiv preprint 4 The viral load of the novel coronavirus, severe acute respiratory syndrome coronavirus 2 56 (SARS-CoV-2), has been reported to peak within the first week of disease in throat and 57 sputum samples in the adult population [1] [2] . The viral loads in a small group of 58 asymptomatic infected adults were also shown to be similar to those of symptomatic 59 infected adults, implying a transmission potential of asymptomatic patients [2] . perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted September 2, 2020. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted September 2, 2020. Although we were unable to establish if the virus was already detectable in high viral loads 148 in the pre-symptomatic phase in our cohort of patients, the high viral load in our 149 symptomatic children in the very early stage of illness implies the transmission potential of 150 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted September 2, 2020. . https://doi.org/10.1101/2020.08.31.20185488 doi: medRxiv preprint

Viral load of SARS-CoV-2 in clinical samples

SARS-CoV-2 viral load in upper respiratory specimens of infected patients

A case series of children with 2019 novel coronavirus infection: clinical and 218 epidemiological features

Clinical and epidemiological features of 36 children with coronavirus disease 222 2019 (COVID-19) in Zhejiang, China: an observational cohort study

Epidemiology of COVID-19 among children in China

A well infant with coronavirus disease 2019 with high viral load

Environment and personal protective equipment tests for SARS-CoV-2 in 232 the isolation room of an infant with infection

pre-symptomatic children if they are not identified and isolated in the pre-symptomatic 151 phase. 152 153 Contrary to reports of COVID-19-infected adults showing similar viral load trends in 154 asymptomatic and symptomatic infected individuals [2] , our findings revealed that 155 symptomatic COVID-19-infected children may have higher viral loads in the initial stage of 156 illness than asymptomatic children. Mi et al recently reported similar findings from a 157 smaller cohort in South Korea but daily swab data was not available [11] . Importantly, even 158 after we accounted for the estimated day of infection for both symptomatic and 159 asymptomatic children, the viral loads continued to be higher in symptomatic children. This 160 suggests that symptomatic children may have a higher risk of transmitting the virus than 161 asymptomatic children. This finding and our daily viral load data could be used to guide 162 modelling work to help undertand the role of children in driving transmisison in schools and 163 the wider population, in order to inform public health interventions including future 164 vaccination policies. 165 166 We found that the majority of patients had detectable virus even on day 7 of 167 illness/diagnosis and the mean duration of viral shedding was 16 days. If testing resources 168 need to be preserved, we suggest that infected children do not need to be tested for the 169 virus for at least the first 7 days of illness/diagnosis to confirm they no longer need to be 170 isolated unless clinically indicated. Isolation of pediatric COVID-19 cases to prevent ongoing 171 transmission may need to continue for at least 2 to 3 weeks. Children with epidemiological 172 links to confirmed cases in the household and schools should be placed under quanratine 173 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted September 2, 2020. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted September 2, 2020. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted September 2, 2020. . https://doi.org/10.1101/2020.08.31.20185488 doi: medRxiv preprint All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted September 2, 2020. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted September 2, 2020. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted September 2, 2020. . https://doi.org/10.1101/2020.08.31.20185488 doi: medRxiv preprint